MTNB — Matinas BioPharma Holdings, Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1582554 ·
Last close
$2.87
Market Cap
$42.17M
52W High
$6.60
52W Low
$0.15
ADV30
534,444
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -1,555,000 | -1,326,000 | 3,412,000 | 761,000 | 1,612,000 |
| Mar 2026 | 0 | — | -1,936,000 | -1,921,000 | 5,874,000 | 2,398,000 | 2,852,000 |
| Dec 2025 | 0 | — | -1,600,000 | -1,912,000 | 7,208,000 | 3,999,000 | 2,378,000 |
| Sep 2025 | 0 | — | -1,577,000 | -1,532,000 | 9,695,000 | 5,435,000 | 3,235,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,605,000
Investing CF
$335,000
Financing CF
$1,744,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.06
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-212,708,000
Inventory
—
Receivables
—
ST Investments
$0
EBIT TTM
$-6,950,000
Pretax Income TTM
$-10,610,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,960,000 | -10,345,000 | 7,208,000 | 2,378,000 | 4,830,000 | -7,011,000 |
| Dec 2024 | 0 | -20,162,000 | -24,251,000 | 12,641,000 | 5,051,000 | 7,590,000 | -15,885,000 |
| Dec 2023 | 1,096,000 | -23,766,000 | -22,942,000 | 25,104,000 | 5,858,000 | 19,246,000 | -15,278,000 |
| Dec 2022 | 3,188,000 | -24,590,000 | -20,997,000 | 44,819,000 | 8,182,000 | 36,637,000 | -19,156,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$7,785,000
NetIncome TTM
$-10,610,000
OpCashFlow TTM
—
Assets (Latest)
$5,874,000
Forward EPS
$-3.00
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VERU | VERU INC. | $41.94M | $2.46 | — |
| NSRX | Nasus Pharma Ltd | $41.12M | $3.51 | — |
| GRCE | Grace Therapeutics, Inc. | $43.75M | $2.08 | — |
| SCYX | SCYNEXIS INC | $40.59M | $4.08 | — |
| PRRUF | IMMUTEP Ltd | $44.21M | $0.03 | — |
News headlines (Yahoo Finance, 1h cache)
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
2026-09-04 21:00 · Yahoo
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
2026-04-03 21:00 · Yahoo
GH Power Signs Multi-Year Hydrogen Offtake Agreement with Change Energy for Hamilton Facility Output
2026-09-14 12:30 · Yahoo
GH Power and TKMS Continue to Explore Clean Energy Collaboration in Support of Canada’s Future Patrol Submarine Project
2026-07-30 12:00 · Yahoo
GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Public through Business Combination with Matinas BioPharma
2026-07-13 19:45 · Yahoo
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
2026-06-26 21:15 · Yahoo
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Te
2026-07-13 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.